SOPHiA GENETICS to Announce Financial Results for Second Quarter 2025 on August 5, 2025

Rhea-AI Summary

SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company specializing in data-driven medicine, has scheduled its second quarter 2025 financial results announcement for August 5, 2025, before U.S. markets open.

The company will host a conference call to discuss the results and business outlook at 8:00 AM EDT / 2:00 PM CET. Investors can access the live webcast through the SOPHiA GENETICS Investor Relations Website, where a replay will also be available after the event.

News Market Reaction – SOPH

-1.72%

1 alert

-1.72% Session move

-2.4% Trough Tracked

$248.61M Market Cap

0.5x Rel. Volume

In the trading session that priced this news, SOPH declined 1.72%, reflecting a mild negative market reaction. Argus tracked a trough of -2.4% from its starting point during tracking.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BOSTON and ROLLE, Switzerland, July 22, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced it will release its financial results for the second quarter 2025 before U.S. markets open on Tuesday, August 5, 2025. On that day, SOPHiA GENETICS will host a conference call to discuss its financial results as well as business outlook beginning at 8:00 a.m. (08:00) EDT / 2:00 p.m. (14:00) CET.

The call will be webcast live on the SOPHiA GENETICS Investor Relations Website. Additionally, a replay will be available on the website after its completion.

About SOPHiA GENETICS

SOPHiA GENETICS (Nasdaq: SOPH) is a software company on a mission to expand access to data-driven medicine by using AI to deliver world-class care to patients with cancer and rare disorders across the globe. It is the creator of the SOPHiA DDM™ Platform, a cloud-native platform that analyzes complex multimodal data – including genomics, radiomics, clinical, biological, and digital pathology data – to generate real-time, actionable insights for a broad global network of hospital, laboratory, and biopharma institutions. For more information, visit SOPHiAGENETICS.COM and connect with us on LinkedIn.

View original content to download multimedia:https://www.prnewswire.com/news-releases/sophia-genetics-to-announce-financial-results-for-second-quarter-2025-on-august-5-2025-302509646.html

SOURCE SOPHiA GENETICS

FAQ

When will SOPHiA GENETICS (SOPH) release Q2 2025 earnings?

SOPHiA GENETICS will release its Q2 2025 financial results on Tuesday, August 5, 2025, before U.S. markets open.

What time is the SOPHiA GENETICS Q2 2025 earnings call?

The earnings conference call is scheduled for 8:00 AM EDT / 2:00 PM CET on August 5, 2025.

How can I access SOPHiA GENETICS (SOPH) Q2 2025 earnings call?

The call will be available via live webcast on the SOPHiA GENETICS Investor Relations Website. A replay will also be available after the call.

What will SOPHiA GENETICS discuss in their Q2 2025 earnings call?

The company will discuss their Q2 2025 financial results and business outlook during the conference call.